Home
Find a Pharmacy
Health News
Medications
Conditions
RxCoupons
Pharmacy Solutions
Find a Pharmacy
Health News
Medications
Conditions
RxCoupons
Pharmacy Solutions
FDA Alerts
Tolvaptan has Liver Injury Risk Says FDA
Otsuka and FDA notified healthcare professionals of significant liver injury associated with the use of Samsca.
REFINE
medications
(-)
Remove Samsca filter
Samsca
conditions
(-)
Remove Kidney Disease filter
Kidney Disease